stockrowCAMP4 Therapeutics Corporation
CAMPCAMP4 Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.5 million, up 436.5% from fiscal 2024.
- Revenue
- +138.9%
- EPS
- +32.7%
- Free cash flow
- +20.4%
Quarter to September 2026, against a year earlier
Follow CAMP
Alert me
CAMP4 Therapeutics Corporation (CAMP) Return on invested capital
CAMP4 Therapeutics Corporation's return on invested capital over the twelve months to 30 September 2026 was 0.00%, down 0.0 percentage points from fiscal 2025 (0.00%). That is in line with the Biotechnology industry median of 0.00% and in line with the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 0.00% | 0.00 |
| FY2024 | 0.00% | 17,526.69 |
| FY2023 | −17,526.7% | (15,736.39) |
| FY2022 | −1,790.3% | — |
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| LRMR Larimar Therapeutics, Inc. compare | 0.00% |
| CAMP CAMP4 Therapeutics Corporation | 0.00% |
| ABEO Abeona Therapeutics Inc. compare | 0.00% |
| FATE Fate Therapeutics, Inc. compare | 0.00% |
| EVMN Evommune Inc. compare | −82.5% |
| VNDA Vanda Pharmaceuticals Inc. compare | −180.2% |
| LCTX Lineage Cell Therapeutics, Inc. compare | −186.8% |
| IMRX Immuneering Corporation compare | −198.4% |
| LXEO Lexeo Therapeutics, Inc. compare | −253.5% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)